Skip to main content
NCBI home page
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1991 Jun 11;19(11):2897–2906. doi: 10.1093/nar/19.11.2897

Anthracycline antibiotic arugomycin binds in both grooves of the DNA helix simultaneously: an NMR and molecular modelling study.

M S Searle 1, W Bicknell 1, L P Wakelin 1, W A Denny 1
PMCID: PMC328249  PMID: 1647521

Abstract

Perturbations to the 1H and 31P chemical shifts of DNA resonances together with twenty-four intermolecular nuclear Overhauser effects show that the anthracycline antibiotic arugomycin intercalates between the basepairs of the hexamer duplex d(5'-GCATGC)2 at the 5'-CpA and 5'-TpG binding sites. In the complex two drug molecules are bound per duplex with full retention of the dyad symmetry. Arugomycin adopts a threaded binding orientation with chains of sugars positioned in both the major and minor groove of the helix simultaneously. The complex is stabilized by hydrogen bonding, electrostatic and van der Waals interactions principally in the major groove and involving substituents on the rigidly oriented bicycloamino-glucose sugar of the antibiotic. A specific hydrogen bond is identified between the C2'-hydroxyl and the guanine N7 at the intercalation site. Together, interactions in the major groove appear to account for the intercalation specificity of arugomycin that requires both a guanine and thymine at the intercalation site. We are unable to identify any sequence specific interactions between the minor groove and the arugarose sugar (S1) which binds only weakly, through van der Walls contacts, over the d(GCA).d(TGC) trinucleotide sequence. The data indicate that the sugar chains of arugomycin are flexible and play little part in the interaction of the antibiotic with DNA. The intensity of sequential internucleotide NOEs identifies the intercalation site as being assymmetric. A family of conformers computed using restrained energy minimisation and molecular dynamics indicate that basepair buckling is a feature of the anthracycline intercalation site that may serve to maximise intermolecular van der Waals interactions by wrapping the basepairs around the antibiotic chromophore.

Full text

PDF
2897

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhuyan B. K., Reusser F. Comparative biological activity of nogalamycin and its analogs. Cancer Res. 1970 Apr;30(4):984–989. [PubMed] [Google Scholar]
  2. Chazin W. J., Wüthrich K., Hyberts S., Rance M., Denny W. A., Leupin W. 1H nuclear magnetic resonance assignments for d-(GCATTAATGC)2 using experimental refinements of established procedures. J Mol Biol. 1986 Aug 5;190(3):439–453. doi: 10.1016/0022-2836(86)90014-8. [DOI] [PubMed] [Google Scholar]
  3. Fox K. R., Brassett C., Waring M. J. Kinetics of dissociation of nogalamycin from DNA: comparison with other anthracycline antibiotics. Biochim Biophys Acta. 1985 Jul 5;840(3):383–392. doi: 10.1016/0304-4165(85)90219-3. [DOI] [PubMed] [Google Scholar]
  4. Fox K. R. Footprinting studies on the interactions of nogalamycin, arugomycin, decilorubicin and viriplanin with DNA. Anticancer Drug Des. 1988 Dec;3(3):157–168. [PubMed] [Google Scholar]
  5. Fox K. R., Waring M. J. Evidence of different binding sites for nogalamycin in DNA revealed by association kinetics. Biochim Biophys Acta. 1984 Nov 28;802(2):162–168. doi: 10.1016/0304-4165(84)90157-0. [DOI] [PubMed] [Google Scholar]
  6. Hare D. R., Wemmer D. E., Chou S. H., Drobny G., Reid B. R. Assignment of the non-exchangeable proton resonances of d(C-G-C-G-A-A-T-T-C-G-C-G) using two-dimensional nuclear magnetic resonance methods. J Mol Biol. 1983 Dec 15;171(3):319–336. doi: 10.1016/0022-2836(83)90096-7. [DOI] [PubMed] [Google Scholar]
  7. Lesser D. R., Kurpiewski M. R., Jen-Jacobson L. The energetic basis of specificity in the Eco RI endonuclease--DNA interaction. Science. 1990 Nov 9;250(4982):776–786. doi: 10.1126/science.2237428. [DOI] [PubMed] [Google Scholar]
  8. Li L. H., Kuentzel S. L., Murch L. L., Pschigoda L. M., Krueger W. C. Comparative biological and biochemical effects of nogalamycin and its analogs on L1210 leukemia. Cancer Res. 1979 Dec;39(12):4816–4822. [PubMed] [Google Scholar]
  9. Liaw Y. C., Gao Y. G., Robinson H., van der Marel G. A., van Boom J. H., Wang A. H. Antitumor drug nogalamycin binds DNA in both grooves simultaneously: molecular structure of nogalamycin-DNA complex. Biochemistry. 1989 Dec 26;28(26):9913–9918. doi: 10.1021/bi00452a006. [DOI] [PubMed] [Google Scholar]
  10. Patel D. J. Peptide antibiotic-oligonucleotide interactions. Nuclear magnetic resonance investigations of complex formation between actinomycin D and d-ApTpGpCpApT in aqueous solution. Biochemistry. 1974 May 21;13(11):2396–2402. doi: 10.1021/bi00708a025. [DOI] [PubMed] [Google Scholar]
  11. Patel D. J. Proton and phosphorus NMR studies of d-CpG(pCpG)n duplexes in solution. Helix-coil transition and complex formation with actinomycin-D. Biopolymers. 1976 Mar;15(3):533–558. doi: 10.1002/bip.1976.360150310. [DOI] [PubMed] [Google Scholar]
  12. Plumbridge T. W., Brown J. R. The effect of modification at the carbocyclic ring of nogalamycin on the interaction DNA. Biochem Pharmacol. 1979 Nov 1;28(21):3231–3234. doi: 10.1016/0006-2952(79)90068-6. [DOI] [PubMed] [Google Scholar]
  13. Pommier Y., Schwartz R. E., Zwelling L. A., Kohn K. W. Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Biochemistry. 1985 Nov 5;24(23):6406–6410. doi: 10.1021/bi00344a014. [DOI] [PubMed] [Google Scholar]
  14. Searle M. S., Hall J. G., Denny W. A., Wakelin L. P. NMR studies of the interaction of the antibiotic nogalamycin with the hexadeoxyribonucleotide duplex d(5'-GCATGC)2. Biochemistry. 1988 Jun 14;27(12):4340–4349. doi: 10.1021/bi00412a022. [DOI] [PubMed] [Google Scholar]
  15. Shimosaka A., Kawai H., Hayakawa Y., Komeshima N., Nakagawa M., Seto H., Otake N. Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification. J Antibiot (Tokyo) 1987 Sep;40(9):1283–1291. doi: 10.7164/antibiotics.40.1283. [DOI] [PubMed] [Google Scholar]
  16. Tewey K. M., Rowe T. C., Yang L., Halligan B. D., Liu L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science. 1984 Oct 26;226(4673):466–468. doi: 10.1126/science.6093249. [DOI] [PubMed] [Google Scholar]
  17. Ughetto G., Wang A. H., Quigley G. J., van der Marel G. A., van Boom J. H., Rich A. A comparison of the structure of echinomycin and triostin A complexed to a DNA fragment. Nucleic Acids Res. 1985 Apr 11;13(7):2305–2323. doi: 10.1093/nar/13.7.2305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Wang A. H., Ughetto G., Quigley G. J., Rich A. Interactions between an anthracycline antibiotic and DNA: molecular structure of daunomycin complexed to d(CpGpTpApCpG) at 1.2-A resolution. Biochemistry. 1987 Feb 24;26(4):1152–1163. doi: 10.1021/bi00378a025. [DOI] [PubMed] [Google Scholar]
  19. Williams L. D., Egli M., Qi G., Bash P., van der Marel G. A., van Boom J. H., Rich A., Frederick C. A. Structure of nogalamycin bound to a DNA hexamer. Proc Natl Acad Sci U S A. 1990 Mar;87(6):2225–2229. doi: 10.1073/pnas.87.6.2225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Zhang X. L., Patel D. J. Solution structure of the nogalamycin-DNA complex. Biochemistry. 1990 Oct 9;29(40):9451–9466. doi: 10.1021/bi00492a020. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES